Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Early Drug Development Summit 2012

03 Dec 2012 - 04 Dec 2012 - Berlin, Germany



Bookmark and Share


The Early Drug Development Summit is taking place on 3rd-4th December 2012 at the Hotel Palace Berlin, Germany. 

This leading industry summit brings early drug developers together to discuss maximising drug investments, toxicology, safety and biomarkers.  

How should companies address strategies and tools to fully optimise their drug development trajectory to bringing safe, effective and commercially viable drugs to market faster whilst achieving regulatory approval? 

•         Andreas Schneider, Vice President Life Science Alliances, Roche - 

Maximising drug investments by effectively managing early drug development pipelines through the use of knowledge management.

•         Dr Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare 

Obtaining grants for biomarkers – setting up open innovation in drug development between industry and academia

•         Amer Alghbban, Director Global Quality Auditing, Merck Serono

Overcoming stringent regulatory barriers – accelerating drug approvals by meeting the requirements of ICH S4

Find out more at www.eddsummit.com 

Save £300 on your registration when booking on www.eddsummit.com/offer 

For further information or to book your place email Michaela Melcher, michaela.melcher@wtgevents.com or call +44(0)20 7202 7690



Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!